29.7 C
New York
Thursday, June 4, 2026

Tag: interview

Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award

Chris Persel of Centre for Neuro Skills receives the first-ever Enduring Contributions Award from ABAI's Brain Injury Special Interest Group.

POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity

Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany

Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.

Musician supported by learning disability charity Hft to showcase his band’s musical journey at Sheffield DocFest

Matthew Watson lead singer of the 'most punk rock band in Britain' Ultimate Thunder, and his bandmates are the focus of a new documentary...

RVezy Turns 10 With a Push to Make Campground Delivery the Easiest Way Canadians Try RV Travel

Two-week anniversary promotion gives Canadian families $100 off campground delivery, helping them stay closer to the lake, the water park, or the family reunion.OTTAWA,...

GENESIS HOUSE PRESENTS MANIFESTING MARILYN: THE MAKING OF AN ICON, A CENTENNIAL REFRAMING OF MARILYN MONROE AS DREAMER, STRATEGIST AND SELF-AUTHOR

Centennial exhibition exploring Marilyn Monroe's intellect, discipline and self-authorshipRare archival personal items, audio and imagery, plus programming and culinary experiences across Genesis HouseNEW YORK,...

Immutable and Ubisoft to Debut Might & Magic Fates at Gamescom 2025

SYDNEY, Aug. 15, 2025 /PRNewswire/ -- Immutable and Ubisoft will unveil Might & Magic Fates for the very first time at Gamescom 2025 Hall 10.1...

Global Times: Unitree founder Wang Xingxing to People’s Daily: Maintaining an open mindset toward industry ups and downs, holding greater confidence in its future

BEIJING, Aug. 13, 2025 /PRNewswire/ -- This year, Unitree Robotics' humanoid robots have gone viral, drawing unprecedented attention to China's humanoid robotics development. Alongside praise...

Glasgow 2026 appoints Trivandi to deliver groundbreaking new format Commonwealth Games

GLASGOW, Scotland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- In a move set to redefine the delivery of world-class sporting events, Glasgow 2026 Commonwealth Games has appointed Trivandi, a global leader in the planning, design and operational delivery of major events as Official Event Delivery Partner.

FORTUNE BAY PROVIDES CORPORATE UPDATE AND OUTLINES PROGRESS ACROSS GOLD PORTFOLIO

Strategic Milestones Ahead as Fortune Bay Advances Cycle-Aligned Gold Assets HALIFAX, NS, Aug. 12, 2025 /CNW/ - Fortune Bay Corp. (TSXV: FOR) (FWB: 5QN) (OTCQB:...

Monster Energy’s Mike Varga Wins Pro Men’s BMX Contest at Final Stop of the 2025 Monster Army Recon Tour in Riverside, California

Canadian Rider Varga Takes 1st Place in Pro Men's Division at The Dreamyard, the iconic BMX Park of the late Pat CaseyMonster Army's Gustavo...

Meet the Global Elite Team—-Marco’s Insights on Chassis Engineering & Pizza Philosophy

GUANGZHOU, China, Aug. 11, 2025 /PRNewswire/ -- GAC is forging world-class chassis technology by synergizing top-tier international engineering expertise with China's signature innovation speed,...

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInterview